
Triple receptor agonist targeting GLP-1, GIP, and glucagon pathways
An account is required to view pricing and purchase research supplies. You will be asked to confirm research-use attestations when you register.
Sign in or create an accountThese products are intended for laboratory research use only and are not for human consumption. Not for use in food, drug, household, or cosmetic applications. All research should be conducted in accordance with applicable safety guidelines and regulations.
Retatrutide is a novel triple agonist that simultaneously engages GLP-1, GIP, and glucagon receptors within a single peptide molecule. This triple-receptor approach represents a significant advance in multi-pathway metabolic research, offering scientists a tool to study the convergence of incretin and glucagon signaling.
Phase 2 clinical data for retatrutide revealed substantial metabolic effects attributable to coordinated activation of three distinct receptor pathways, positioning it as a next-generation compound for metabolic research.
Store lyophilized at -20°C, tightly sealed, away from heat, light and moisture. Once reconstituted, refrigerate at 2-8°C and use within 28 days.
Reconstitute with bacteriostatic water for multi-dose use (supports the 28-day refrigerated window), or an appropriate sterile diluent per your research protocol. Allow the vial to reach room temperature before reconstitution.
Stable for 18-36 months when stored lyophilized at -20°C or below, sealed and protected from light and moisture. Once reconstituted, use within 28 days refrigerated at 2-8°C.
For Research Use Only — Not for Human or Animal Consumption. This is a general laboratory dilution calculator (mass-to-volume concentration math) for in vitro research planning. It is not medical guidance, not a dosing tool, and not intended to support administration to humans or animals. All Nuvopeptide products are sold exclusively for in vitro laboratory research and have not been evaluated by the FDA.